Clinical Resources Core

临床资源核心

基本信息

项目摘要

Although some improvement has been made since the Oklahoma Shared Clinical and Translational Resources (OSCTR) initiation, Oklahoma remains consistently in or near the bottom 10% of states for the overall health of its population. Oklahoma’s residents disproportionately suffer from chronic health problems, such as obesity, diabetes, cardiovascular disease, and arthritis/autoimmunity. Oklahomans have a life expectancy of 4 years shorter than the average US citizen, while American Indians have a life expectancy of more than 7 years shorter than other groups within the US. With high percentages of rural (34%) and tribal (16%) populations, Oklahoma has unique challenges and opportunities to implement clinical and translational research (CTR) projects and dissemination and implementation research to improve health and disease outcomes. The Clinical Resources (ClinRes) Core of the OSCTR has built a centralized system to support human subjects research focused on these issues. The Core provides clinical research facilities and staff to assist with participant recruitment and regulatory approvals, a CAP-certified Biorepository that has allowed the OSCTR to adopt or establish registries, repositories, and cohorts to assist investigators in obtaining and utilizing high-quality samples to support their research efforts, and infrastructure for accessing de-identified patient data to support clinical research projects. These efforts have allowed the Core to support the careers of multiple CTR investigators, including researchers who are members of the under-represented minority communities in the state. The ClinRes Core will continue to provide this invaluable access to sample collections while supporting the establishment and growth of new repositories focusing on the health issues of greatest concern to our populations, including cancer, diabetes, and arthritis. The ClinRes core will continue to work with the Community Engagement and Outreach (CEO) Core to build on the strong relationships developed with smaller community organizations across the state during the COVID-19 pandemic. Together, these collaborations enhance the overall opportunities of our CTR investigators to expand clinical study and trial access to residents throughout the state to help increase participant diversity and address our rural and minority health disparities. The ClinRes Core will continue to provide junior investigators with essential assistance with institutional IRB applications, protocols, data safety monitoring boards, and other regulatory requirements and will work with the Administrative Core to make access to resources and information more accessible to investigators, clinicians, clinical research staff, and participants through the Gateway to Oklahoma portal. With the CEO Tribal Engagement Unit, we will assist investigators in working with the Indian Health Service and tribal IRBs, ensuring the protection of both individual human subjects and tribal community populations. Finally, we will continue developing and supporting resources to grow our clinical research informatics capacity to facilitate local and national research efforts.
尽管自俄克拉何马州共享临床和转化资源以来已经取得了一些进步

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Robert Hal Scofield其他文献

Autoantibodies identify primary Sjögren's syndrome in patients lacking serum IgG specific for Ro/SS-A and La/SS-B
自身抗体在缺乏针对 Ro/SS-A 和 La/SS-B 的血清 IgG 的患者中识别原发性干燥综合征
  • DOI:
    10.1136/ard-2022-223105
  • 发表时间:
    2023-09-01
  • 期刊:
  • 影响因子:
    20.600
  • 作者:
    Sherri Longobardi;Charmaine Lopez-Davis;Bhuwan Khatri;Constantin Georgescu;Cherilyn Pritchett-Frazee;Christina Lawrence;Astrid Rasmussen;Lida Radfar;Robert Hal Scofield;Alan N Baer;Susan A Robinson;Erika Darrah;Robert C Axtell;Gabriel Pardo;Jonathan D Wren;Kristi A Koelsch;Joel M Guthridge;Judith A James;Christopher J Lessard;Amy Darise Farris
  • 通讯作者:
    Amy Darise Farris

Robert Hal Scofield的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Robert Hal Scofield', 18)}}的其他基金

Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10854472
  • 财政年份:
    2023
  • 资助金额:
    $ 61.68万
  • 项目类别:
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
  • 批准号:
    9892288
  • 财政年份:
    2020
  • 资助金额:
    $ 61.68万
  • 项目类别:
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
  • 批准号:
    10427168
  • 财政年份:
    2020
  • 资助金额:
    $ 61.68万
  • 项目类别:
Autoimmunity in Post-Traumatic Stress Disorder
创伤后应激障碍中的自身免疫
  • 批准号:
    10704565
  • 财政年份:
    2020
  • 资助金额:
    $ 61.68万
  • 项目类别:
Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10450830
  • 财政年份:
    2019
  • 资助金额:
    $ 61.68万
  • 项目类别:
ShEEP Request for Peggy Sue by Bio-Techne
ShEEP 请求 Bio-Techne 提供 Peggy Sue
  • 批准号:
    9906453
  • 财政年份:
    2019
  • 资助金额:
    $ 61.68万
  • 项目类别:
Sjogren's Syndrome Pathogenic Autoantibodies
干燥综合征致病性自身抗体
  • 批准号:
    10213695
  • 财政年份:
    2019
  • 资助金额:
    $ 61.68万
  • 项目类别:
Mitochondrial dysfunction, metabolic syndrome and oxidative damage in Sjogren's Syndrome
干燥综合征中的线粒体功能障碍、代谢综合征和氧化损伤
  • 批准号:
    9387723
  • 财政年份:
    2017
  • 资助金额:
    $ 61.68万
  • 项目类别:
Clinical Core
临床核心
  • 批准号:
    8712123
  • 财政年份:
    2014
  • 资助金额:
    $ 61.68万
  • 项目类别:
Clinical Research Core
临床研究核心
  • 批准号:
    10218194
  • 财政年份:
    2013
  • 资助金额:
    $ 61.68万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 61.68万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了